Disease Modeling of CADASIL Using Human-Induced Pluripotent Stem Cell-Derived Mural Cells
Overview
Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) is an extremely rare neurological small vessel disease, affecting about 2-5 people every 100,000 globally, defined by the NOTCH3 mutation (Khan, et al., 2020). The aim of this study was to establish a disease model for CADASIL using human induced pluripotent stem cells (hiPSC)-derived mural cells to represent the disease pathogenesis of CADASIL through validation of hiPSC-derived mural cells and functional analysis. Validation of hiPSC-derived mural cells were performed through qPCR and lmmunofluorescence. There was a significantly lower expression of PDGFRB and NG2 in CADASIL cell lines (p < 0.0001), suggesting dysregulation in mural cells function, compromised angiogenic potential, and impaired vascular development in CADASIL. To examine the calcium influx of CADASIL vs. Non-CADASIL cell lines, the brightness intensity was quantified, followed by the addition of ionomycin to accentuate the calcium signal. Furthermore, there was significantly higher calcium influx in CADASIL cell lines (p< 0.05), indicating elevated levels of Ca2+ due to the vasoconstriction. Cell migration rates of mural cells were compared using the Scratch assay. The Scratch assay demonstrated that PC from Non-CADASIL exhibited a faster proliferation rate compared to CADASIL (p < 0.05). Through the MTT Assay, the healthy control mural cells exhibited significantly higher absorbance compared to CADASIL mural cells (p < 0.001), indicating reduced proliferation rate in CADASIL-derived mural cells. As the hiPSC-derived MC provided an effective model for CADASIL, the research has implications for future drug development and improved diagnosis, allowing further investigation of CADASIL pathogenesis.
Competition history
- AJAS 2025
Related projects
ISEF · 2024
Establishing Disease Modeling of CADASIL Using Human Induced Pluripotent Stem Cell-Derived Pericytes
ISEF · 2015
Diabetic Stem Cell Derived Cardiomyocytes in Disease Modeling and Therapeutic Discovery
ISEF · 2016
mTOR Regulates the Phenotypic Modulation of De-differentiated Mesenchymal Stem Cells in Vascular Disease
ISEF · 2016
Building Blood Vessel-like Structures using Stem Cell Derived Endothelial Cells
ISEF · 2014
Induced Pluripotent Stem Cell-Derived Cardiomyocytes as a Model for Ischemia Reperfusion Injury
ISEF · 2023
3D Human Stem Cell Model for Neural Development
ISEF · 2025
Investigating Impacts of the E736D COL22A1 Mutation Upon Vascular Stability and Hemorrhagic Incidence in an Embryonic Zebrafish Model
ISEF · 2025
Uncovering Molecular Mechanisms for Treatment of Congenital Heart Defects Through High-Content Genetic Perturbation Screens
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: AAAS Annual Meeting (Confex) / American Junior Academy of Science